OCS.
company based in Latvia
- Reports this week
- 2
- Active events
- 3
- Connections
- 62
What's happening
Active this week
-
OCS, a global biopharmaceutical company, is mentioned in the context of Oculis's research involving Anat Galor.Some support1 report
-
Minneapolis City Council proposed eliminating OCS, prompting Jacob Frey to warn that the move would jeopardize city services.Some support1 report
-
OCS team is located within the Greater Chennai Corporation's Adyar zone.Some support1 report
Earlier this month
-
OCS is filing reports with the SEC and trading on the NASDAQ stock exchange.Some support2 reports
-
OCS, led by CEO Sherif, sponsored an event in New Orleans on October 7, 2026.Some support1 report
-
OCS is anticipated to become a new revenue stream for the company, building on its partnership with Nvidia.Some support3 reports
-
Summit 2026 is taking place in Las Vegas, Nevada, with OCS sponsoring clinical trials.Some support3 reports
One to three months ago
-
OCS is listed on the Nasdaq stock exchange and its financial reporting is tied to the US market.Some support2 reports1 development inside
-
CS overreach is impacting the operational independence of OCS in Kenya.Some support1 report
-
OCS is now a revenue segment of ADI.Some support1 report
-
OCS and North Sails participated in the XOD regatta on August 2, 2026.Some support2 reports
-
OCS is acquiring Mitie Group plc through a Scheme of Arrangement.Well supported7 reports1 development inside
-
OCS recommended a cash acquisition of Mitie shares, with Chetan Patel holding shares requiring irrevocable undertakings.Some support1 report
-
A £5.1bn bid for easyJet was announced, while OCS acquired Mitie Group plc shares at a premium.Some support1 report
Gone quiet
No new reports in 90+ days-
OCS is seeking Priority Medicines and Breakthrough Therapy designations for Privosegtor for optic neuritis from the FDA and EMA.Some support2 reports
-
An investigation into OCS is underway, focusing on market integrity issues in New York City.Some support2 reports
-
The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.Some support3 reports
-
Oculis Holding AG secured an upsized loan facility from BlackRock and issued results from Zug, Switzerland.Some support2 reports1 development inside
-
Nathan Miller assists in Oculis securities investigation.Some support1 report
-
OCS appointed Sebastian Wolf as Chief Medical Advisor for Ophthalmology in Zug on August 25, 2025.Some support1 report
-
OCS technology is cited as a key factor driving the growth of Transmedics.Some support4 reports1 development inside
-
OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.Some support5 reports
-
BlackRock began managing funds for Oculis' loan facility.Some support1 report
-
OCS appointed Snehal Shah as President of R&D on August 12, 2025.Some support1 report
-
OCS collaborated with EURETINA on an award, recognizing Prithvi Ramtohul with the Tadayoni Award, which was presented by Anat Loewenstein.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around OCS this week
News at the entities that move OCS most-
FDA StructuralFDA-approved products are subject to Controlled Substances Act rules, impacting TerrAscend's operations across Pennsylvania, Maryland, New Jersey, and Ohio.Moves OCS
-
ADI StructuralADI tribes oppose the Siang project in India, which is framed as a countermeasure to dam-building in Tibet.Moves OCS
-
European Medicines Agency StructuralBoth the FDA and European Medicines Agency must adopt evidence-based principles for drug regulation.Moves OCS
-
Nasdaq StructuralFreight Technologies, Inc. began trading on the Nasdaq market on October 19, 2026.Moves OCS
-
Kenya StructuralGlobal oil market disruptions from the Middle East conflict are impacting fuel imports through Mombasa, Kenya.Moves OCS
-
London Stock Exchange StructuralOxford Instruments was listed on the FTSE250 index on March 19, 2026.Moves OCS
Connections
The 35 strongest of 62, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Transmedics Structural
OCS technology is the core product driving Transmedics' growth and market operations in organ transplant procedures.
-
ADI Structural
OCS functions as a defined revenue segment within the corporate structure of ADI.
-
European Medicines Agency Structural
OCS is undergoing the formal regulatory review process with the European Medicines Agency, culminating in the PRIME designation for its product.
-
FDA Structural
OCS relies on the FDA for product approval, clearance, and regulatory designations like Breakthrough Therapy.
-
Nasdaq Structural
OCS is formally listed and trades shares on the Nasdaq stock exchange.
-
Sherif Structural
Sherif holds the role of CEO at OCS.
-
Kenya Structural
Kenya's regulatory actions (CS overreach) impact the operational independence of OCS.
-
London Stock Exchange Structural
OCS relies on the London Stock Exchange as the operational venue for executing its corporate acquisitions.
Show all 35 connections
-
SUMMIT Transactional
OCS is providing financial sponsorship for clinical trials being held at the Summit 2026 infrastructure event.
-
Nvidia Operational
OCS is anticipated to derive new revenue streams from its operational relationship with Nvidia's market.
-
Minneapolis City Council Structural
The Minneapolis City Council is proposing the elimination of OCS.
-
Anat Galor Operational
OCS features Anat Galor as a key opinion leader in its corporate communications.
-
Lumentum Holdings Transactional
Lumentum benefits commercially from OCS's pricing structure.
-
MarketBeat Mentioned together
MarketBeat provides average rating data and tracking information for OCS.
-
Galatea Mentioned together
The evidence suggests OCS is mentioned in the context of market leadership that impacts competitors.
-
BlackRock Transactional
BlackRock provides loan facility management and financing to OCS.
-
Nathan Miller Transactional
Nathan Miller is engaged to provide expert assistance regarding OCS's securities investigation.
-
Jacob Frey Structural
Jacob Frey warned that the elimination of OCS would jeopardize essential services.
-
Nairobi Operational
OCS actively collaborates with county teams in Nairobi.
-
New York City Shared context
OCS operates within the market and regulatory context of New York City, which is currently under investigation regarding market integrity issues.
-
Securities and Exchange Commission Structural
OCS is subject to formal regulatory oversight by the SEC, requiring the filing of official reports.
-
Canton of Zug Shared context
OCS conducts corporate events and issues results while located in the Canton of Zug.
-
Switzerland Shared context
OCS is headquartered and operates in Switzerland.
-
Greater Chennai Corporation Shared context
OCS operates within the administrative zone managed by the Greater Chennai Corporation.
-
Y. Chen Mentioned together
The evidence is insufficient to establish a relationship between OCS and Y. Chen.
-
Lorain County Shared context
OCS operates within the jurisdiction of Lorain County, providing support services to its residents.
-
Adyar Shared context
OCS maintains a physical presence within the Adyar zone.
-
MIaMI Shared context
OCS management is scheduled to attend a conference in Miami.
-
Iceland Shared context
OCS maintains operational presence and holds investor meetings within Iceland.
-
New Orleans Shared context
OCS is observed sponsoring an event within the geographical context of New Orleans.
-
Nevada Shared context
The single piece of evidence places an event in Nevada, but provides no direct coupling or interaction between Nevada and OCS.
-
Microsoft Mentioned together
No evidence was found linking OCS and Microsoft in the provided timeline.
-
Google Mentioned together
No direct relationship between OCS and Google is observed in the provided evidence.
-
North Sails Shared context
Both companies shared a context by participating in the XOD regatta.
-
William Ruto Mentioned together
The provided evidence does not describe a relationship between OCS and William Ruto.
History
Events by the month they beganOctober 2026
4 events- OCS, a global biopharmaceutical company, is mentioned in the context of Oculis's research involving Anat Galor.
- Minneapolis City Council proposed eliminating OCS, prompting Jacob Frey to warn that the move would jeopardize city services.
- OCS team is located within the Greater Chennai Corporation's Adyar zone.
- OCS, led by CEO Sherif, sponsored an event in New Orleans on October 7, 2026.
September 2026
1 eventAugust 2026
5 events- OCS is anticipated to become a new revenue stream for the company, building on its partnership with Nvidia.
- OCS is listed on the Nasdaq stock exchange and its financial reporting is tied to the US market.
- CS overreach is impacting the operational independence of OCS in Kenya.
- OCS is now a revenue segment of ADI.
- OCS and North Sails participated in the XOD regatta on August 2, 2026.
Show 2 earlier months
July 2026
4 events- OCS is acquiring Mitie Group plc through a Scheme of Arrangement.
- OCS recommended a cash acquisition of Mitie shares, with Chetan Patel holding shares requiring irrevocable undertakings.
- A £5.1bn bid for easyJet was announced, while OCS acquired Mitie Group plc shares at a premium.
- OCS is seeking Priority Medicines and Breakthrough Therapy designations for Privosegtor for optic neuritis from the FDA and EMA.
June 2026
11 events- Summit 2026 is taking place in Las Vegas, Nevada, with OCS sponsoring clinical trials.
- An investigation into OCS is underway, focusing on market integrity issues in New York City.
- The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.
- Oculis Holding AG secured an upsized loan facility from BlackRock and issued results from Zug, Switzerland.
- Nathan Miller assists in Oculis securities investigation.
- OCS appointed Sebastian Wolf as Chief Medical Advisor for Ophthalmology in Zug on August 25, 2025.
- OCS technology is cited as a key factor driving the growth of Transmedics.
- OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.
- BlackRock began managing funds for Oculis' loan facility.
- OCS appointed Snehal Shah as President of R&D on August 12, 2025.
- OCS collaborated with EURETINA on an award, recognizing Prithvi Ramtohul with the Tadayoni Award, which was presented by Anat Loewenstein.